GlassScriptPhysician profile
David F Hettinger
NPI 1821099276
$1,287.15
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $166 · 2022: $512 · 2023: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $136.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $222.59 | 2019-2020 | |
| Horizon Therapeutics Plc | $167.20 | 2019-2022 | |
| Fusion Orthopedics USA, LLC | $136.56 | 2023 | |
| Royal Biologics, INC. | $119.39 | 2019 | |
| Angiodynamics, INC. | $107.22 | 2022 | |
| Tactile Systems Technology INC | $106.42 | 2019 | |
| Paratek Pharmaceuticals, INC. | $98.36 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $94.61 | 2022 | |
| Medline Industries LP | $94.14 | 2019 | |
| Collaborative Care Diagnostics, LLC | $47.99 | 2022 | |
| Abbott Laboratories | $46.01 | 2022 | |
| Integra Lifesciences Corporation | $27.38 | 2020 | |
| Organogenesis INC. | $19.28 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hettinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.